论文部分内容阅读
The heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) was reported to be participated in variety of tumors development.Previously,we isolated an hnRNP A1-specific DNA aptamer BC15,that can evaluate hnRNP A1 expression in liver cancer and inhibit hnRNP A1,which could be a potential drug candidate for hepatocarcinoma treatment.